Tresa McGranahan
Neurology · Encinitas, CANPI 1639519010
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Servier Pharmaceuticals LLC accounts for 98.0% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $31,537, more than ten times the $27 reported in 2022. Among neurology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $1114.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$52K
- Deciphera Pharmaceuticals Inc.$620
- Johnson & Johnson$67
- Novocure Inc.$52
- Eisai Inc.$50
- Merck$48
- plus $232 from 8 others
Across 17 payments — averaging $7785.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Servier Bioinnovation$37K
- Servier Pharmaceuticals LLC$34K
- Novocure GmbH$31K
- Agios Pharmaceuticals, Inc.$30K
What the payments were for
- Consulting fees$22,02541%
- Speaking & faculty fees$29,46355%
- Travel & lodging$8042%
- Food & beverage$1,2132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 29 | $52,436 |
| Deciphera Pharmaceuticals Inc. | 1 | $620 |
| Johnson & Johnson | 3 | $67 |
| Novocure Inc. | 2 | $52 |
| Eisai Inc. | 2 | $50 |
| Merck | 2 | $48 |
| Caris MPI, Inc. | 2 | $42 |
| Karyopharm Therapeutics Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Pharmaessentia USA Corporation | 1 | $28 |
| Genentech USA, Inc. | 1 | $28 |
| Novartis | 1 | $28 |
| GE HealthCare | 1 | $24 |
| Tempus AI, Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Voranigo$29,825
How this compares
$53,505 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GleostineLomustine | 14 | $12,324 |
| Levetiracetam | 87 | $4,927 |
| Lacosamide | 24 | $1,135 |
| Memantine Hcl | 17 | $872 |
| Dexamethasone | 47 | $852 |
| Zonisamide | 43 | $559 |
| Lamotrigine | 16 | $436 |
| Divalproex Sodium | 11 | $427 |
| Quetiapine Fumarate | 13 | $420 |
| Gabapentin | 23 | $327 |
| Duloxetine Hcl | 12 | $249 |
| Escitalopram Oxalate | 13 | $237 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $192 |
| Ondansetron Hcl | 27 | $188 |
| Pantoprazole Sodium | 16 | $177 |
Paid to pharmacies, not to this prescriber.
Other neurology in Encinitas
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.